Data / Form D filings / Kubanda Cryotherapy, Inc.
Kubanda Cryotherapy, Inc.: Form D filings
Kubanda Cryotherapy, Inc., a biotechnology company in Baltimore, MD, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on April 25, 2024, reports $200,000 sold of a $200,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3600 CLIPPER MILL ROAD, SUITE 310, Baltimore, MD, 21202
- Phone
- (405) 501-4070
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1853949
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 25, 2024 | New notice | $200,000 | $200,000 | 1 | Apr 22, 2024 | sec.gov | |
| Apr 17, 2024 | New notice | $2,200,000 | $725,000 | $1,475,000 | 15 | Aug 11, 2023 | sec.gov |
| Apr 2, 2021 | New notice | $450,000 | $100,000 | $350,000 | 2 | Mar 22, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bailey Surtees | Executive Officer, Director, Promoter | |
| Yixin Hu | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
Every Form D from the week of Apr 22, 2024 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kubanda Cryotherapy, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.